Influence of CYP2D6*2 and CYP2D6*4 alleles on phenotype in polymedicated depressed inpatients: therapeutic consequences?
Haffen
E
E
Vandel
P
P
Paintaud
G
G
Broly
F
F
Vandel
S
S
Bonin
B
B
Bizouard
P
P
Sechter
D
D
Bechtel
P R
PR
D000293:Adolescent; D000328:Adult; D000368:Aged; D000483:Alleles; D000928:Antidepressive Agents / Q000378:metabolism* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000378:metabolism* / Q000627:therapeutic use; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics* / Q000378:metabolism; D003866:Depressive Disorder / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D005260:Female; D005838:Genotype; D006801:Humans; D007297:Inpatients; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D016896:Treatment Outcome
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D019389:Cytochrome P-450 CYP2D6